SCHEMBL5013858

SCHEMBL5013858

CC1CSC(C)C(C(=O)N2CCc3[c]nc(C(N)=O)nc3C2)C1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4982838 0.78 GRM5 (0.38) GRM5
SCHEMBL4990989 0.76 GRM5 (0.35) GRM5
SCHEMBL4988438 0.76 KEAP1 (0.40) GRM5
SCHEMBL4985602 0.75 KEAP1 (0.42) GRM5
SCHEMBL4986931 0.74 ACACB (0.37) GRM5
SCHEMBL4988240 0.73 CNR2 (0.42)
SCHEMBL5013859 0.71 GRM5 (0.32) GRM5
SCHEMBL4988610 0.70 CGAS (0.36) GRM5
SCHEMBL4980898 0.70 DPP4 (0.34)
SCHEMBL4985064 0.70 CNR2 (0.36) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 GRM5 231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.